154 related articles for article (PubMed ID: 8735682)
21. Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis.
Braillon A; Calès P; Lebrec D
Int J Clin Pharmacol Res; 1985; 5(4):223-8. PubMed ID: 4055165
[TBL] [Abstract][Full Text] [Related]
22. The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis.
Grose RD; Plevris JN; Redhead DN; Bouchier IA; Hayes PC
J Hepatol; 1994 Apr; 20(4):542-7. PubMed ID: 8051395
[TBL] [Abstract][Full Text] [Related]
23. [The long-term effect of molsidomine on frequency of hemorrhage, portal and cardiac hemodynamics in patients with liver cirrhosis--a pilot study].
Hüppe D; Jäger D; Tromm A; Barmeyer J; May B
Leber Magen Darm; 1993 May; 23(3):114-8, 121-2. PubMed ID: 8326815
[TBL] [Abstract][Full Text] [Related]
24. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
Lin HC; Yang YY; Hou MC; Huang YT; Lee FY; Lee SD
Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
[TBL] [Abstract][Full Text] [Related]
25. Systemic and splanchnic hemodynamic effects of molsidomine in rats with carbon tetrachloride-induced cirrhosis.
Desmorat H; Vinel JP; Lahlou O; Pipy B; Badia P; Cales P; Combis JM; Souqual MC; Pascal JP
Hepatology; 1991 Jun; 13(6):1181-4. PubMed ID: 2050332
[TBL] [Abstract][Full Text] [Related]
26. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
[TBL] [Abstract][Full Text] [Related]
27. Effect of propranolol on hepatic blood flow in patients with cirrhosis.
Braillon A; Jirón MI; Valla D; Calès P; Lebrec D
Clin Pharmacol Ther; 1985 Apr; 37(4):376-80. PubMed ID: 3978998
[TBL] [Abstract][Full Text] [Related]
28. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
Albillos A; Lledó JL; Rossi I; Pérez-Páramo M; Tabuenca MJ; Bañares R; Iborra J; Garrido A; Escartín P; Bosch J
Gastroenterology; 1995 Oct; 109(4):1257-65. PubMed ID: 7557093
[TBL] [Abstract][Full Text] [Related]
29. Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.
Merkel C; Finucci G; Zuin R; Bazzerla G; Bolognesi M; Sacerdoti D; Gatta A
J Hepatol; 1987 Apr; 4(2):174-80. PubMed ID: 3584925
[TBL] [Abstract][Full Text] [Related]
30. Portal hemodynamics during nitroglycerin administration in cirrhotic patients.
Garcia-Tsao G; Groszmann RJ
Hepatology; 1987; 7(5):805-9. PubMed ID: 3115881
[TBL] [Abstract][Full Text] [Related]
31. Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis.
Bosch J; Masti R; Kravetz D; Bruix J; Gaya J; Rigau J; Rodes J
Hepatology; 1984; 4(6):1200-5. PubMed ID: 6500511
[TBL] [Abstract][Full Text] [Related]
32. Effect on hemodynamics of a liquid meal alone and in combination with propranolol in cirrhosis.
Bendtsen F; Simonsen L; Henriksen JH
Gastroenterology; 1992 Mar; 102(3):1017-23. PubMed ID: 1537493
[TBL] [Abstract][Full Text] [Related]
33. Effects of atorvastatin on portal hemodynamics and clinical outcomes in patients with cirrhosis with portal hypertension: a proof-of-concept study.
Bishnu S; Ahammed SM; Sarkar A; Hembram J; Chatterjee S; Das K; Dhali GK; Chowdhury A; Das K
Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):54-59. PubMed ID: 29099421
[TBL] [Abstract][Full Text] [Related]
34. Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis.
Mastai R; Bosch J; Navasa M; Kravetz D; Bruix J; Viola C; Rodés J
J Hepatol; 1987 Feb; 4(1):71-9. PubMed ID: 3033061
[TBL] [Abstract][Full Text] [Related]
35. Effect of oral propranolol on splanchnic oxygen uptake and haemodynamics in patients with cirrhosis.
Bendtsen F; Henriksen JH; Becker U; Sørensen TI
J Hepatol; 1987 Oct; 5(2):137-43. PubMed ID: 3693857
[TBL] [Abstract][Full Text] [Related]
36. Comparative haemodynamic effects of betaxolol and propranolol in patients with cirrhosis.
Braillon A; Lee SS; Valla D; Geoffroy P; Sauvanet JP; Lebrec D
Scand J Gastroenterol; 1988 Aug; 23(6):691-5. PubMed ID: 2902683
[TBL] [Abstract][Full Text] [Related]
37. Haemodynamic effects of propranolol, octreotide and their combination during fasting and post-prandial splanchnic hyperaemia in patients with cirrhosis.
Sabbà C; Buonamico P; Vendemiale G; Berardi E; Antonica G; Palmieri V; Merkel C; Palasciano G
Eur J Gastroenterol Hepatol; 2001 Feb; 13(2):163-9. PubMed ID: 11246616
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.
Garcia-Pagán JC; Navasa M; Bosch J; Bru C; Pizcueta P; Rodés J
Hepatology; 1990 Feb; 11(2):230-8. PubMed ID: 2307401
[TBL] [Abstract][Full Text] [Related]
39. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis.
Bandi JC; García-Pagán JC; Escorsell A; François E; Moitinho E; Rodés J; Bosch J
Hepatology; 1998 Sep; 28(3):677-82. PubMed ID: 9731558
[TBL] [Abstract][Full Text] [Related]
40. Oral administration of nipradilol and the acute and chronic splanchnic hemodynamic effects of a new beta-blocker with nitrovasodilating properties in patients with liver cirrhosis.
Sugano S; Kawafune T; Suzuki T; Kubota M; Okajima T; Sumino Y; Akita H
Am J Gastroenterol; 1995 May; 90(5):788-93. PubMed ID: 7733089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]